Skip to content

Contact +44 (0) 20 7060 7474 email us

Technology

Hematology Analyzer Instrumentation and Reagent Markets

 

Publication Date July 2009
Publisher TriMark Publications
Product Type Report
Pages 147
ISBN Number TMRHEMA07-0124
Product Code TRI00065

Price

£2,245.00
approximately: $3,399 | €2,506

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Clinical hematology analyzer analysis is one of the oldest and most important sectors of clinical laboratory analysis. The hematology instrument and reagent market is centered around a group of instruments called hematology analyzers. The term clinical hematology analyzer usually refers to an automated instrument for determining the presence, number and type of cellular elements in easily collected body fluids, such as blood. However, it is not necessarily limited to these determinations. The hematology analysis always includes determination of non-cellular parameters in blood, such as hemoglobin and hematocrit. Other closely related areas of clinical interest are coagulation and flow cytometry. In fact, traditional specialization barriers, such as microbiology, hematology, blood banking, immunology and even anatomical pathology are rapidly fading both operationally and instrumentally. But for the sake of defining the subject to a reasonable size, the more traditional scope of clinical hematology analyzer will be the focus of this examination. The purpose of this TriMark Publications report is to describe the specific segments of the global clinical hematology analyzer instrumentation and reagent marketplace. The review covers those segments that are highly active in terms of innovation and growth. Specifically, this study examines the markets for small-lab, as well as highly-automated large-lab, platforms and accessory equipment, such as reagents, supplies and add-on equipment from original equipment manufacturers.

Contents

  • 1. Overview
    • 1.1 Objectives of the Report
    • 1.2 Methodology
    • 1.3 Scope of the Report
    • 1.4 Executive Summary
  • 2. IVD Clinical Hematology Analyzer Market
    • 2.1 Introduction
    • 2.2 Key Product Segments
      • 2.2.1 Hematology and Associates Instruments
        • 2.2.1.1 Hematology Analyzers
        • 2.2.1.2 Hematology Instruments Offerings by Major Players
        • 2.2.1.2.1 Hematology Reagents and Controls
        • 2.2.1.2.2 Hematology Point of Care Instruments
        • 2.2.1.3 Flow Cytometers
        • 2.2.1.3.1 Flow Cytometry Technology Platforms
        • 2.2.1.3.2 Clinical Applications of Flow Cytometry
        • 2.2.1.3.2.1 Leukocyte Analysis
        • 2.2.1.3.2.2 Immunophenotyping of Leukemias and Lymphomas
        • 2.2.1.3.2.3 Neutropenia
        • 2.2.1.3.2.4 Platelet Analysis
        • 2.2.1.3.2.5 T Cell Subsets
        • 2.2.1.3.2.6 Reticulocyte Count
        • 2.2.1.3.3 Flow Cytometry Market Growth
        • 2.2.1.3.3.1 Applications
        • 2.2.1.3.3.2 Market Size
        • 2.2.1.3.3.3 Instrumentation Preferences
        • 2.2.1.3.3.4 Reagent Selection and Use
        • 2.2.1.3.3.5 Instrument Manufacturers
        • 2.2.1.3.3.6 Future Directions of Flow Cytometry
        • 2.2.1.4 Coagulation Analyzers
        • 2.2.1.4.1 Coagulation Market Size
        • 2.2.1.4.2 Prothrombin Time Test
        • 2.2.1.4.3 Activated Partial Thromboplastin Time (APTT)
        • 2.2.1.4.4 Clinical Advantages of Coagulation Testing
        • 2.2.1.4.5 Coagulation Instruments
        • 2.2.1.4.5.1 Roche Diagnostics
        • 2.2.1.4.5.2 Avocet Medical (Acquired by Beckman Coulter, Inc.)
        • 2.2.1.4.5.3 International Technidyne Corporation (ITC)
        • 2.2.1.4.5.4 Diagnostica Stago's STA-RE Evolution
        • 2.2.1.4.5.5 Other Companies
        • 2.2.1.4.5.6 Coagulation Reagents
        • 2.2.1.5 Hemoglobinometers
        • 2.2.1.6 Slide Stainers
        • 2.2.1.7 Differential Counters
        • 2.2.1.8 Hematology Stains
    • 2.3 Blood Components
      • 2.3.1 Complete Blood Count (CBC)
      • 2.3.2 Red Blood Cells (RBCs)
      • 2.3.3 White Blood Cells (WBCs)
      • 2.3.4 Platelets
      • 2.3.5 Hematocrit (HCT)
    • 2.4 Hematology Tests
    • 2.5 The Coulter Principle
    • 2.6 Blood Collection
  • 3. Global Analyzer Market
    • 3.1 Global Markets
      • 3.1.1 Global Drivers of Clinical Hematology Analyzer Testing
      • 3.1.2 Global Outlook
      • 3.1.3 U.S. Market
      • 3.1.4 European Market
        • 3.1.5.1 German Clinical Hematology Analyzer and Reagent Diagnostic Markets
        • 3.1.5.2 U.K. Clinical Hematology Market
        • 3.1.5.3 French Clinical Hematology Market
        • 3.1.5.4 Italian Clinical Hematology Market
        • 3.1.5.5 Spanish Clinical Hematology Market
        • 3.1.5.6 Belgian Clinical Hematology Market
        • 3.1.5.7 Swiss Clinical Hematology Market
        • 3.1.5.8 Dutch Clinical Hematology Market
        • 3.1.5.9 Portuguese Clinical Hematology Market
        • 3.1.5.10 Austrian Clinical Hematology Market
        • 3.1.5.11 Greek Clinical Hematology Market
        • 3.1.5.12 Polish Clinical Hematology Market
        • 3.1.5.13 Czech Clinical Hematology Market
        • 3.1.5.14 Finnish Clinical Hematology Market
        • 3.1.5.15 Scandinavian Clinical Hematology Market
      • 3.1.6 Asian Market
        • 3.1.6.1 Indian Clinical Hematology Market
        • 3.1.6.1.1 India's in vitro Diagnostic Testing Industry
        • 3.1.6.1.2 Major Indian IVD Companies
        • 3.1.6.2 Japanese Clinical Hematology Market
        • 3.1.6.3 Chinese Clinical Hematology Market
      • 3.1.7 Country Clinical Hematology Smaller Markets
        • 3.1.7.1 Canada Clinical Hematology Market
        • 3.1.7.2 Brazil Clinical Hematology Market
        • 3.1.7.3 Turkey Clinical Hematology Market
        • 3.1.7.4 Australia Clinical Hematology Market
      • 3.1.8 Remaining World Clinical Hematology Market
      • 3.1.9 Overview of Asian Healthcare Market
        • 3.1.9.1 Singapore
        • 3.1.9.2 Malaysia
        • 3.1.9.3 Thailand
        • 3.1.9.4 Indonesia
        • 3.1.9.5 Philippines
        • 3.1.9.6 South Korea
        • 3.1.9.7 Hong Kong
      • 3.1.10 Overview of the Latin American Diagnostics Market
    • 3.2 Clinical Hematology Analyzer and Reagents Sector
      • 3.2.1 Industry-Served Markets
      • 3.2.2 Industry Players
        • 3.2.2.1 Manufacturing Companies
      • 3.2.3 Market Specialization
      • 3.2.4 Hematology Sector Companies
    • 3.3 Outlook for Clinical Hematology Analyzer Testing
      • 3.3.1 Long-Term Changes
      • 3.3.2 Market Drivers
      • 3.3.3 The Limits to Growth
      • 3.3.4 Hot Sectors in the IVD Market
      • 3.3.5 Key Technologies
      • 3.3.6 Conclusion
  • 4. Clinical Hematology Instrument Market by Type and Competitor
    • 4.1 Abbott Diagnostics
    • 4.2 Siemens Healthcare Diagnostics
    • 4.3 Beckman Coulter, Inc
    • 4.4 Drew Scientific Group
    • 4.5 Horiba ABX Inc
    • 4.6 Sysmex Corporation
    • 4.7 Boule Medical AB
    • 4.8 Beijing ShiningSun Technology Co., Ltd
    • 4.9 Hematology Analyzers for Point of Care
  • 5. Important Technology Trends
    • 5.1 Technology Platform Innovations in Hematology Testing
    • 5.2 The New Paradigm
    • 5.3 Consolidated Workstations
    • 5.4 Automation in the Laboratory
    • 5.5 Laboratory Information Systems
    • 5.6 New User-friendly Interfaces
    • 5.7 Data-Management Issues
      • 5.7.1 Wireless LANs
      • 5.7.2 Data and Workflow Management Systems
      • 5.7.3 Beckman Central Command Central Version 2.0
      • 5.7.4 Middleware
    • 5.8 Robotics - Total Laboratory Automation Robotic Sample Handling
    • 5.9 Image Analysis
    • 5.10 Flow Cytometry
    • 5.11 Laser Technology
    • 5.12 Automating Preanalytics
    • 5.13 Telepathology
  • 6. Business Trends in the Clinical Hematology Analyzer Sector
    • 6.1 Key Developments
    • 6.2 Industrial Sector Consolidation
    • 6.3 Hospital and Commercial Laboratory Consolidation
    • 6.4 Changing Ordering Patterns
    • 6.5 New Products
    • 6.6 Acquisition, License Agreements, Internal Development and Partnerships
    • 6.7 Breadth of Product Offerings
    • 6.8 Government Regulation
      • 6.8.1 U.S. Regulation
        • 6.8.1.1 Importing Medical Devices into the U.S
        • 6.8.1.2 Exporting Medical Devices from the U.S
      • 6.8.2 U.K. Regulation
      • 6.8.3 E.U. Regulation
      • 6.8.4 Japanese Regulation
      • 6.8.5 Korean Regulation
    • 6.9 Costs of Doing Business in Europe
    • 6.10 Drivers of European Diagnostics Testing
    • 6.11 European Reimbursement Practices
    • 6.12 Cost Containment in Europe
    • 6.13 Revenue and Reimbursement
  • 7. Product Launches
    • 7.1 Horiba ABX Unveils Pentra DX 120
    • 7.2 Sysmex to Launch Sales of the XT-4000i Hematology Analyzers
    • 7.3 Laser Scan Cytometry System
    • 7.4 Abbott Receives Clearance for Hematology Instrument
    • 7.5 Vital Diagnostics announced the Addition of the Excyte Mini Automated ESR Analyzer
    • 7.6 Becton Introduces FACSCanto II
    • 7.7 Abbott's International Launch of CELL-DYN Emerald??? Hematology Instrument
    • 7.8 Beckman Coulter Launches UniCel DxH 800
    • 7.9 Beckman Launches High-Performance Hematology Analyzer Ac???T
    • 7.10 Abbott Laboratories Released its Cell-Dyn 1800 Automated Hematology Analyzer
    • 7.11 BD (Becton Dickinson Biosciences) Imagn System
    • 7.12 Sysmex Network Communications System
    • 7.13 Sysmex XT-V Multi-Species Hematology Analyzer
    • 7.14 The Melet Schloesing MS4-5
    • 7.15 Roche CoaguChek XS Plus System
    • 7.16 Sysmex Corp Launches KX-4500
    • 7.17 Streck nRBC-Chex
    • 7.18 HORIBA ABX Introduces Micros CRP 200
    • 7.19 Heska Corporation Introduces Veterinary Hematology Analyzer
    • 7.20 Specialized Master Software Programs for the Sysmex XE-2100 Hematology Analyzers
    • 7.21 HORIBA ABX e-Sat module
    • 7.22 Medonic M series Hematology Analyzer
    • 7.23 Streck's ESR-AutoPlus
    • 7.24 Streck Quality Control Reagents
  • 8. Clinical Hematology Testing Sector Trends and Forecasts
    • 8.1 Home Care Analysis
    • 8.2 Non-Traditional Collection for Hematology Analyzer Testing
    • 8.3 New Systems for Critical-Care and Near-Patient Testing
    • 8.4 Utility of Near-Patient Testing in Critical-Care Settings
    • 8.5 Mergers of Diagnostic Companies
    • 8.6 Information Management Advances
    • 8.7 Test Ordering Patterns
    • 8.8 Patient Satisfaction
    • 8.9 Move Away From Central Laboratory
    • 8.10 Healthcare Cost Controls
    • 8.11 Competition for Services
    • 8.12 Drivers of Clinical Hematology analyzer Testing
    • 8.13 Confluence of New Technology
    • 8.14 New Trends in Clinical Laboratory Testing
      • 8.14.1 Trends in Reimbursement Practices
      • 8.14.2 Managed Care
      • 8.14.3 Changes in Patient Management
      • 8.14.4 Focused Testing
      • 8.14.5 Satellite Facilities
    • 8.15 Demographic Trends
  • 9. Company Profiles
    • 9.1 Abbott Diagnostics
    • 9.2 A.Menarini Diagnostics
    • 9.3 Bayer HealthCare, AG
    • 9.4 Beckman Coulter, Inc
    • 9.5 Becton Dickenson Biosciences
    • 9.6 Boule Diagnostics International AB
    • 9.7 Cholestech Corporation
    • 9.8 Dade Behring (Acquired by Siemens)
    • 9.9 HemoCue, Inc
    • 9.10 Heska Corporation
    • 9.11 Horiba Group
    • 9.12 MELET SCHLOESING Laboratories
    • 9.13 Micronics, Inc
    • 9.14 Nihon Kohden Corporation
    • 9.15 PPD (Pharmaceutical Product Development, Inc.)
    • 9.16 Roche Diagnostics (F. Hoffmann-La Roche, Ltd.)
    • 9.17 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
    • 9.18 Streck, Inc
    • 9.19 Sysmex Corporation
  • LIST OF TABLES
    • Table 2.1: Clinical Hematology Tests Submitted to Medicare, 2005-2012
    • Table 2.2: Clinical Hematology Tests Performed in the U.S., 2005-2012
    • Table 2.3: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2009
    • Table 2.4: Competitive Landscape: Companies Participating in the Hematology IVD Sector
    • Table 2.5: Key Product Segments
    • Table 2.6: Worldwide Market for Flow Cytometry Instruments and Reagents, 2000-2010
    • Table 2.7: Worldwide Market for Rapid Coagulation Testing Dollar Volume, 2000-2008
    • Table 2.8: U.S. Market for Rapid Coagulation Testing Dollar Volume, 2000-2008
    • Table 2.9: U.S. Market for Rapid Coagulation POC Testing Dollar Volume, 2001-2012
    • Table 2.10: Slide Stainer Instruments and Manufacturers
    • Table 2.11: Hematology Stains
    • Table 3.1: The Overall In Vitro Diagnostic Testing Market Worldwide, 2008
    • Table 3.2: Worldwide Distribution of IVD Testing, 2008
    • Table 3.3: Global Clinical Hematology Analyzer and Reagent Revenues, 2005-2012
    • Table 3.4: Worldwide Distribution of Clinical Hematology Testing Analyzer and Reagent Revenues, 2006
    • Table 3.5: Ten Largest Diagnostic Companies Worldwide, 2007
    • Table 3.6 Key Players in Worldwide Hematology Analyzers and Reagent Market
    • Table 3.7: Leading Players in Worldwide Coagulation Analyzer and Reagent Market
    • Table 3.8: U.S. Clinical Hematology Analyzer Testing Market, 2000-2011
    • Table 3.9: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2007
    • Table 3.10: Leading Players in the U.S. Hematology Analyzers Market
    • Table 3.11: Leading Players in the U.S. Coagulation Analyzers Market
    • Table 3.12: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
    • Table 3.14: European Clinical Laboratory Testing Diagnostics by Country Market Estimates, 2007
    • Table 3.15: European Clinical Hematology Instrument and Reagent Testing Market, 2000-2008
    • Table 3.16: German Hematology Reagent Market Sales, 2003-2012
    • Table 3.17: UK Hematology Reagent Market Sales, 2003-2012
    • Table 3.18: French Hematology Reagent Market Sales, 2003-2012
    • Table 3.19: Italian Hematology Reagent Market Sales, 2003-2012
    • Table 3.20: Spanish Hematology Reagent Market Sales, 2003-2012
    • Table 3.21: Belgian Hematology Reagent Market Sales, 2003-2012
    • Table 3.22: Swiss Hematology Reagent Market Sales, 2003-2012
    • Table 3.23: Dutch Hematology Reagent Market Sales, 2003-2012
    • Table 3.24: Portuguese Hematology Reagent Market Sales, 2003-2012
    • Table 3.25: Austrian Hematology Reagent Market Sales, 2003-2012
    • Table 3.26: Greek Hematology Reagent Market Sales, 2003-2012
    • Table 3.27: Polish Hematology Reagent Market Sales, 2003-2012
    • Table 3.28: Czech Hematology Reagent Market Sales, 2003-2012
    • Table 3.29: Finnish Hematology Reagent Market Sales, 2003-2012
    • Table 3.30: Scandinavian Clinical Hematology Diagnostics Products Market Sales, 2002-2008
    • Table 3.31: Indian IVD Market, 2006-2012
    • Table 3.32: Indian Hematology Reagent Market Sales, 2006-2012
    • Table 3.33: Number of Automated Clinical Labs in India, 2004-2012
    • Table 3.34: Indian IVD Market, 2008
    • Table 3.36: Japanese Clinical Hematology Testing Market, 2000-2008
    • Table 3.37: Chinese Clinical Hematology Reagent Market Sales, 2000-2008
    • Table 3.38: Canadian Clinical Hematology Testing Market, 2000-2008
    • Table 3.39: Brazilian Clinical Hematology Analyzer Testing Market, 2000-2008
    • Table 3.40: Turkish Clinical Hematology Reagents Testing Market, 2000-2008
    • Table 3.41: Australian Clinical Hematology Reagents Testing Market, 2000-2008
    • Table 3.42: The ROW Clinical Hematology Reagents Testing Market, 2000-2008
    • Table 3.43: Estimated Number of Clinical Laboratories in Latin America
    • Table 3.44: Principal Marketers of Automated Clinical Hematology Analyzer Instruments
    • Table 4.1: Linearity and Precision of Abbott CELL-DYN Hematology Analyzers
    • Table 4.2: Accuracy of the Automated Differential of Abbott CELL-DYN Analyzers
    • Table 4.3: Linearity and Precision of Siemens Hematology Analyzers
    • Table 4.4: Accuracy of the Automated Differential of Siemens Hematology Analyzers
    • Table 4.5: Linearity and Precision of Beckman Coulter Hematology Instruments
    • Table 4.6: Accuracy of the Automated Differential of Beckman Coulter Hematology Analyzers
    • Table 4.7: Linearity and Precision of Horiba ABX Hematology Analyzers
    • Table 4.8: Accuracy of the Horiba ABX Hematology Analyzers
    • Table 4.9: Linearity and Precision of Sysmex Hematology Analyzers
    • Table 4.10: Accuracy of the Sysmex Hematology Analyzers
    • Table 4.11: Comparison of Linearity and Precision of Top-of-the-Line Hematology Analyzers
    • Table 4.12: Comparison of Accuracy of the Top-of-the-Line Hematology Analyzers
    • Table 4.13: Hematology Analyzers with a 5-Part WBC Differential
    • Table 4.14: Hematology Analyzers with a Three-Part WBC Differential
    • Table 5.1: Applications for Wireless LAN Technology
    • Table 8.1: Medicare Billing Guidelines for Multi-channel Hematology Analyzer Tests